Dr Lal PathLabs hits record high in a weak market; surges 19% in 5 days

The company would continue to reap benefits from increased Covid-related and allied testing in its widespread network of diagnostic centers and labs, analysts believe

Shares of Dr Lal PathLabs hit a record high of Rs 2,924.85, ralling 7 per cent on the BSE in the intra-day trade on Monday, on expectation of healthy earning growth in the near-term, as the company would continue to reap benefits from increased Covid-related and allied testing in its widespread network of diagnostic centers and labs.

At 11:03 am, the S&P BSE Sensex was down 2.6 per cent at 48,744 points while the stock was quoting higher for the fifth straight trading day. The stock has rallied 19 per cent, as against a 0.72 per cent gain in